Literature DB >> 26859719

Headache (chronic tension-type).

Mona Ghadiri-Sani1, Nicholas Silver.   

Abstract

INTRODUCTION: Chronic tension-type headache (CTTH) is a disorder that evolves from episodic tension-type headache, with daily, or very frequent, episodes of headache lasting hours or they may be continuous. It affects up to 4% of the general population, and is more prevalent in women (up to 65% of cases). METHODS AND OUTCOMES: We conducted a systematic overview, aiming to answer the following clinical questions: What are the effects of drug treatments for CTTH? What are the effects of non-drug treatments for CTTH? We searched: Medline, Embase, The Cochrane Library, and other important databases up to December 2013 (Clinical Evidence overviews are updated periodically; please check our website for the most up-to-date version of this overview).
RESULTS: At this update, searching of electronic databases retrieved 125 studies. After deduplication, 77 records were screened for inclusion in the overview. Appraisal of titles and abstracts led to the exclusion of 56 studies and the further review of 21 full publications. Of the 21 full articles evaluated, three systematic reviews and one RCT were included at this update. We performed a GRADE evaluation for 15 PICO combinations.
CONCLUSIONS: In this systematic overview, we categorised the efficacy for 12 interventions based on information about the effectiveness and safety of non-drug treatments acupuncture and cognitive behavioural therapy (CBT), as well as the drug treatments amitriptyline, anticonvulsant drugs (sodium valproate, topiramate, or gabapentin), benzodiazepines, botulinum toxin, noradrenergic and specific serotonergic antidepressants (mirtazapine), NSAIDs (e.g. ibuprofen); opioid analgesics (e.g. codeine), paracetamol, serotonin re-uptake inhibitor antidepressants (SSRIs, SNRIs), and tricyclic antidepressants (other than amitriptyline).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26859719      PMCID: PMC4747324     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  30 in total

1.  TREATMENT OF CHRONIC TENSION HEADACHE.

Authors:  J W LANCE; D A CURRAN
Journal:  Lancet       Date:  1964-06-06       Impact factor: 79.321

2.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

3.  Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache.

Authors:  L Bendtsen; L Buchgreitz; S Ashina; R Jensen
Journal:  Eur J Neurol       Date:  2007-02       Impact factor: 6.089

4.  Maprotiline in chronic tension headache: a double-blind cross-over study.

Authors:  R Fogelholm; K Murros
Journal:  Headache       Date:  1985-07       Impact factor: 5.887

5.  Acupuncture in patients with tension-type headache: randomised controlled trial.

Authors:  Dieter Melchart; Andrea Streng; Andrea Hoppe; Benno Brinkhaus; Claudia Witt; Stefan Wagenpfeil; Volker Pfaffenrath; Michael Hammes; Josef Hummelsberger; Dominik Irnich; Wolfgang Weidenhammer; Stefan N Willich; Klaus Linde
Journal:  BMJ       Date:  2005-07-29

6.  Sertraline in chronic tension-type headache.

Authors:  N N Singh; S Misra
Journal:  J Assoc Physicians India       Date:  2002-07

7.  A community-based study of headache diagnosis and prevalence in Singapore.

Authors:  K-H Ho; B K-C Ong
Journal:  Cephalalgia       Date:  2003-02       Impact factor: 6.292

8.  [Treatment of chronic tension type headache with mirtazapine and amitriptyline].

Authors:  A Martín-Araguz; C Bustamante-Martínez; J M de Pedro-Pijoán
Journal:  Rev Neurol       Date:  2003 Jul 16-31       Impact factor: 0.870

9.  Lifetime prevalence and characteristics of recurrent primary headaches in a population-based sample of Swedish twins.

Authors:  Dan A Svensson; Karl Ekbom; Bo Larsson; Elisabet Waldenlind
Journal:  Headache       Date:  2002-09       Impact factor: 5.887

Review 10.  Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.

Authors:  Rita Banzi; Cristina Cusi; Concetta Randazzo; Roberto Sterzi; Dario Tedesco; Lorenzo Moja
Journal:  Cochrane Database Syst Rev       Date:  2015-05-01
View more
  1 in total

Review 1.  Pharmacogenetics in Primary Headache Disorders.

Authors:  Irina I Belyaeva; Anna G Subbotina; Ivan I Eremenko; Vadim V Tarasov; Vladimir N Chubarev; Helgi B Schiöth; Jessica Mwinyi
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.